Copay Assistance Can Be Excluded From Medicaid ‘Best Price’ Without Strings Attached – US Court

Decision is a win for the Pharmaceutical Research and Manufacturers of America in lawsuit against the US Health and Human Services Department.

Court Vacates CMS Requirement That Manufacturers Must Attest Assistance Goes Only To Patients • Source: Shutterstock (Shutterstock)

A federal regulation requiring drug manufacturers to ensure their copay assistance goes only to patients in order for the firms to be allowed to exclude the value of the assistance from Medicaid “best price” calculations was struck down by the US District Court for the District of Columbia in a 17 May decision.

The ruling grants a request from the Pharmaceutical Research and Manufacturers of America for a preliminary injunction barring implementation of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicaid

More from Government Payers